Summary
The hydrolysis of sphingomyelin generates key molecules regulating cell growth and inducing apoptosis. Data from animal cancer models support an inhibitory role for this pathway in the malignant transformation of the colonic mucosa. In the intestinal tract, a sphingomyelinase with an optimum alkaline pH has been identified. We recently found that the activity of alkaline sphingomyelinase is significantly decreased in colorectal adenocarcinomas, indicating a potential anticarcinogenic role of this enzyme. To further examine whether the reduction of sphingomyelinase is present already in the premalignant state of neoplastic transformation, we measured sphingomyelinase activities in patients with familial adenomatous polyposis (FAP) and in sporadic colorectal tubulovillous adenomas. Tissue samples were taken from adenomas and surrounding macroscopically normal mucosa from 11 FAP patients operated with ileorectal anastomosis, from three FAP patients with intact colon, from 13 patients with sporadic colorectal adenomas and from 12 controls. Activities of acid, neutral and alkaline sphingomyelinase were measured together with alkaline phosphatase. In FAP adenoma tissue, alkaline sphingomyelinase activity was reduced by 90% compared to controls (P < 0.0001), acid sphingomyelinase by 66% (P < 0.01) and neutral sphingomyelinase by 54% (P < 0.05). Similar reductions were found in the surrounding mucosa. In sporadic adenoma tissue, only alkaline sphingomyelinase was reduced significantly, by 57% (P < 0.05). Alkaline phosphatase was not changed in FAP adenomas, but decreased in the sporadic adenomas. We conclude that the markedly reduced levels of alkaline sphingomyelinase activities in FAP adenomas and in the surrounding mucosa may be a pathogenic factor that can lead to unrestrained cell proliferation and neoplastic transformation.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baeg, G-H, Matsumine, A & Kuroda, T et al. (1995). The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J 14: 5618–5625.
Browne, SJ, Williams, AC & Hague, A et al. (1994). Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer 59: 59–64.
Chatterjee, S (1994). Neutral sphingomyelinase. Adv Lip Res 26: 25–57.
Dillehay, DL, Sebb, SK & Schmelz, E-M et al. (1994). Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF-1 mice. J Nutr 124: 615–620.
Duan, R-D, Nyberg, L & Nilsson, Å (1995a). Alkaline sphingomyelinase activity in rat gastro-intestinal tract: distribution and characteristics. Biochim Biophys Acta 1259: 49–55.
Duan, R-D, Hertervig, E & Nyberg, L et al. (1995b). The distribution of alkaline sphingomyelinase activity in human beings and animals: tissue and species differences. Dig Dis Sci 41: 1801–1806.
Duan, R-D, Cheng, Y & Tauschel, H-D et al. (1998). Effects of ursodexycholate and other bile salts on levels of rat intestinal sphingomyelinase: a potential implication for tumorigenesis. Dig Dis Sci 43: 226–232.
Dudeja, PK, Dahiya, R & Brasitus, TA et al. (1986). The role of sphingomyelin synthetase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat colonic plasma membranes. Biochim Biophys Acta 863: 309–312.
Earnest, DL, Holubec, H & Wali, RK et al. (1994). Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 54: 5071–5074.
Gatt, S (1975). Magnesium-dependent sphingomyelinase. Biochim Biophys Acta 68: 235–241.
Groden, J, Thliveris, A & Samowitz, W et al. (1991). Identification and characterization of the familial adenomatous polyposis gene. Cell 66: 589–600.
Hannun, YA & Linnardic, CM (1993). Sphingolipid breakdown products: anti-proliferative and tumour-suppressor lipids. Biochim Biophys Acta 1154: 223–236.
Hertervig, E, Nilsson, Å & Nyberg, L et al. (1997). Alkaline sphingomyelinase is decreased in human colorectal carcinoma. Cancer 79: 448–453.
Icii, S, Nakatsuru, S & Furuyama, J et al. (1992). Inactivation of both APC alleles in an early stage of colonic adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet 1: 387–390.
Jen, J, Powell, SM & Papadopoulos, N et al. (1994). Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54: 5523–5526.
Kinzler, KW & Vogelstein, B (1996). Lessons from hereditary cancer. Cell 87: 159–170.
Kinzler, KW, Nilbert, MC & Su, L-K et al. (1991). Identification of FAP locus genes from chromosome 5q21. Science 253: 661–665.
Kolesnik, RN (1991). Sphingomyelin and derivatives as cellular signals. Prog Lipid Res 30: 1–38.
Korinek, V, Barker, N & Morin, PJ et al. (1997). Constitutive transcriptional activation by a β-catenin-Tcf complex in APC–/– colon carcinoma. Science 275: 1784–1787.
Luongo, C, Moser, AR & Gledhill, S et al. (1994). Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54: 5947–5952.
Merchant, TE, Diamantis, PM & Lauwersa, G et al. (1995). Characterization of malignant colon tumours with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles. Cancer 76: 1715–1723.
Morin, PJ, Sparks, AB & Korinek, V et al. (1997). Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790.
Nilsson, Å (1969). The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 176: 339–347.
Nyberg, L, Duan, R-D & Axelson, J et al. (1996). Identification of an alkaline sphingomyelinase in human bile. Biochim Biophys Acta 1300: 42–48.
Nyberg, L, Nilsson, Å & Lungren, P et al. (1997). Localization and capacity of sphingomyelin digestion in the rat intestinal tract. 8: 112–117.
Obeid, LM, Linardic, CM & Karoloak, LA et al. (1993). Programmed cell death induced by ceramide. Science 259: 1769–1771.
Schmelz, EM, Dillehay, DL & Webb, SK et al. (1996). Sphingomyelin consumption suppresses abberant crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res 56: 4936–4941.
Spence, MW (1994). Sphingomyelinases. Adv Lip Res 26: 3–23.
Stoffel, W (1975). Chemical synthesis of choline-labeled lecithins and sphingomyelins. Methods Enzymol 35: 533–541.
Su, L-K, Vogelstein, B & Kinzler, KW (1993). Association of the APC tumour suppressor protein with catenins. Science 262: 1734–1737.
Wong, MH, Hermiston, ML & Syder, AJ et al. (1996). Forced expression of the tumour suppressor adenomatous polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc Natl Acad Sci USA 93: 9588–9593.
Yang, VW, Shields, JM & Hamilton, SR et al. (1998). Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 58: 1750–1753.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hertervig, E., Nilsson, Å., Björk, J. et al. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: A key factor to the unrestrained cell proliferation?. Br J Cancer 81, 232–236 (1999). https://doi.org/10.1038/sj.bjc.6690682
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690682
Keywords
This article is cited by
-
How ceramides affect the development of colon cancer: from normal colon to carcinoma
Pflügers Archiv - European Journal of Physiology (2024)
-
Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase
Cancer Cell International (2022)
-
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography
BMC Gastroenterology (2014)
-
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats
Journal of Cancer Research and Clinical Oncology (2008)
-
Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis
British Journal of Cancer (2007)